Coronary atherosclerotic disease is highly prevalent in chronic kidney disease (CKD).
Although revascularization improves outcomes, procedural risks are increased in CKD, and …

Chronic kidney disease (CKD) might be an important determinant in choosing percutaneous
coronary intervention (PCI) and coronary artery bypass grafting (CABG). However, there is a …

BACKGROUND: Patients with chronic kidney disease (CKD) have high risks of coronary
artery disease (CAD). Coronary revascularization is beneficial for long-term survival, but the …

BACKGROUND: Chronic kidney disease (CKD) is associated with adverse outcomes after
coronary artery bypass graft surgery (CABG) and percutaneous coronary interventions (PCI) …

Background Chronic kidney disease is an independent risk factor for coronary artery
disease and is associated with an increase in adverse outcomes. However, the optimal …

Aims: The aim of this study was to investigate short-term and five-year follow-up results from
patients randomised to coronary artery bypass grafting (CABG) or percutaneous coronary …

Objectives To compare coronary artery bypass grafting (CABG) and percutaneous coronary
intervention (PCI) for revascularising coronary arteries in patients with chronic kidney …

Long-term patient and kidney survival after coronary artery... : Coronary Artery Disease Long-term
patient and kidney survival after coronary artery bypass grafting, percutaneous coronary …

Patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) on dialysis
have an increased risk for cardiovascular mortality and morbidity secondary to occlusive …

Ischemic heart disease is a major risk factor for morbidity and mortality in patients with end-
stage renal disease. However, long-term benefits of percutaneous coronary intervention …